Propranolol (Cardiovascular) drug information

Why is this medication prescribed?
How should this medicine be used?
Other uses for this medicine
What special precautions should I follow?
What special dietary instructions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What should I know about STORAGE and DISPOSAL of this medication?
What should I do in case of OVERDOSE?
What OTHER INFORMATION should I know?
Brand names of combination products
Drug interactions

IMPORTANT WARNING

Do not stop taking propranolol without talking to your doctor first. If propranolol is stopped suddenly, it may cause chest pain or heart attack in some people.

Why is this medication prescribed?

Propranolol is used to treat high blood pressure, irregular heart rhythms, pheochromocytoma (tumor on a small gland near the kidneys), certain types of tremor, and hypertrophic subaortic stenosis (a heart muscle disease). It is also used to prevent angina (chest pain), migraine headaches, and to improve survival after a heart attack. Propranolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

How should this medicine be used?

Propranolol comes as a tablet, solution (liquid),and as an extended-release (long-acting) capsule to take by mouth. The extended-release propranolol capsule (brand name: Inderal LA) usually is taken once a day. The extended-release capsule (Innopran XL, Inderal XL) is usually taken at bedtime and should consistently be taken either always with or always without food each time. Immediate-acting propranolol tablets or solution may be taken two, three, or four times a day. Take propranolol at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take propranolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release capsules whole; do not split, chew, or crush them.

Other uses for this medicine

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

What special precautions should I follow?

Before taking propranolol,

tell your doctor and pharmacist if you are allergic to propranolol, any other medications, or any ingredients in propranolol products. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: ACE inhibitors; antacids containing aluminum (Maalox, Mylanta, others); anticoagulants (''blood thinners'') such as warfarin (Coumadin, Jantoven); calcium channel blockers such as diltiazem (Cardizem, Cartia, Tiazac, others), nicardipine (Cardene), nifedipine (Adalat, Procardia XL), and nisoldipine (Sular); cholestyramine (Prevalite); cimetidine; ciprofloxacin (Cipro); chlorpromazine; colestipol (Colestid); diazepam (Diastat, Valium); digoxin (Lanoxin); fluvoxamine (Luvox); haloperidol (Haldol); HMG-CoA reductase inhibitors (cholesterol-lowering agents) such as lovastatin (Altoprev, Mevacor, in Advicor) and pravastatin (Pravachol); isoniazid (in Rifamate, in Rifater); medications for depression such as bupropion (Aplenzin, Forfivo XL, Wellbutrin, Zyban), fluoxetine (Prozac, Sarafem, Selfemra), imipramine (Tofranil), and paroxetine (Brisdelle, Paxil, Pexeva); fluconazole (Diflucan); medications for migraine headaches such as rizatriptan (Maxalt) and zolmitriptan (Zomig); medications for high blood pressure such as clonidine (Catapres, Kapvay, in Clorpres), doxazosin (Cardura), prazosin (Minipress), and terazosin; medications for seizures such as phenytoin (Dilantin, Phenytek) and phenobarbital; certain medications for irregular heartbeats such as amiodarone (Cordarone, Nexterone, Pacerone), propafenone (Rythmol), and quinidine (in Nuedexta); monoamine oxidase (MAO) inhibitors such as phenelzine (Nardil); montelukast (Singulair); nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin (Indocin, Tivorbex); theophylline (Theo-24, Theochron, Uniphyl); reserpine; rifampin (Rifadin, Rimactane, in Rifater, in Rifamate); ritonavir (Norvir, in Kaletra, in Viekira Pak); teniposide (Vumon); thioridazine; ticlopidine; tolbutamide; tricyclic antidepressants; and zileuton (Zyflo). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

tell your doctor if you have or have ever had asthma or other lung disease; heart, liver, or kidney disease; diabetes; severe allergies; or thyroid problems.

tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking propranolol, call your doctor.

if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking propranolol.

ask your doctor about the safe use of alcoholic beverages while you are taking propranolol. Alcohol may increase the amount of propranolol in your body.

tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.

What special dietary instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What should I do if I forget a dose?

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

What side effects can this medication cause?

Propranolol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- dizziness or lightheadedness
- tiredness
- diarrhea
- constipation

Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:
- difficulty breathing or swallowing
- rash
- blistering or peeling skin
- hives
- itching
- swelling of the face, throat, tongue, or lips
- feeling faint
- weight gain
- irregular heartbeat
Propranolol may cause other side effects. Call your doctor if you have any unusual problems while you are using this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What should I know about STORAGE and DISPOSAL of this medication?

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from light, excess heat, and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

What should I do in case of OVERDOSE?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

slow heartbeat

What OTHER INFORMATION should I know?

Keep all appointments with your doctor and the laboratory.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Brand names of combination products

Inderide^® (containing Hydrochlorothiazide, Propranolol)
Inderide^® LA (containing Hydrochlorothiazide, Propranolol)

Drug interactions

Drug	Interaction
Moxifloxacin	Moxifloxacin The metabolism of Propranolol can be decreased when combined with Moxifloxacin.
Repaglinide	Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Propranolol.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glargine.
Leflunomide	Leflunomide The serum concentration of Propranolol can be decreased when it is combined with Leflunomide.
Delavirdine	Delavirdine The serum concentration of Propranolol can be increased when it is combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Propranolol can be decreased when combined with Nevirapine.
Atorvastatin	Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Propranolol.
Dolasetron	Dolasetron The risk or severity of QTc prolongation can be increased when Propranolol is combined with Dolasetron.
Aminophylline	Aminophylline The risk or severity of adverse effects can be increased when Propranolol is combined with Aminophylline.
Anagrelide	Anagrelide The risk or severity of QTc prolongation can be increased when Propranolol is combined with Anagrelide.
Calcium Carbonate	Calcium Carbonate The therapeutic efficacy of Propranolol can be decreased when used in combination with Calcium carbonate.
Candesartan	Candesartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Candesartan.
Cilostazol	Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Propranolol.
Clopidogrel	Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Propranolol.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The metabolism of Propranolol can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) The metabolism of Propranolol can be decreased when combined with Conjugated estrogens.
Fenofibrate	Fenofibrate The serum concentration of Propranolol can be increased when it is combined with Fenofibrate.
Guanfacine	Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Propranolol.
Magnesium Hydroxide	Magnesium Hydroxide Propranolol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine	Methylergonovine Propranolol may increase the vasoconstricting activities of Methylergometrine.
Miglitol	Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Propranolol.
Mycophenolate	Mycophenolate Propranolol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan	Naratriptan The metabolism of Naratriptan can be decreased when combined with Propranolol.
Olsalazine	Olsalazine Olsalazine may decrease the antihypertensive activities of Propranolol.
Paregoric	Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Propranolol.
Penbutolol	Penbutolol Propranolol may increase the arrhythmogenic activities of Acebutolol.
Potassium	Potassium Potassium may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone Propranolol may decrease the excretion rate of Prednisone which could result in a higher serum level.
Ranitidine	Ranitidine The serum concentration of Ranitidine can be increased when it is combined with Propranolol.
Reserpine	Reserpine Reserpine may increase the hypotensive activities of Propranolol.
Rizatriptan	Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Propranolol.
Sumatriptan	Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Propranolol.
Tacrolimus	Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Propranolol.
Tizanidine	Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Propranolol.
Triamcinolone	Triamcinolone The metabolism of Propranolol can be increased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The serum concentration of the active metabolites of Zolmitriptan can be reduced when Zolmitriptan is used in combination with Propranolol resulting in a loss in efficacy.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Propranolol which could result in a higher serum level.
Famotidine Injection	Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Propranolol.
Fluconazole Injection	Fluconazole Injection The serum concentration of Propranolol can be increased when it is combined with Fluconazole.
Foscarnet Injection	Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Propranolol.
Hydromorphone Injection	Hydromorphone Injection Hydromorphone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Interferon Beta-1b Injection	Interferon Beta-1b Injection The metabolism of Propranolol can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection	Interferon Gamma-1b Injection The metabolism of Propranolol can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection	Levofloxacin Injection The metabolism of Propranolol can be decreased when combined with Levofloxacin.
Meperidine Injection	Meperidine Injection The metabolism of Propranolol can be increased when combined with Meperidine.
Metoclopramide Injection	Metoclopramide Injection The metabolism of Propranolol can be decreased when combined with Metoclopramide.
Metronidazole Injection	Metronidazole Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Metronidazole.
Morphine Injection	Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Propranolol.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Propranolol may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine	Altretamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Amphetamine.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cyclosporine	Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Propranolol.
Ondansetron	Ondansetron The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ondansetron.
Enoxaparin Injection	Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Propranolol is combined with Enoxaparin.
Granisetron	Granisetron The risk or severity of QTc prolongation can be increased when Propranolol is combined with Granisetron.
Torsemide	Torsemide Torasemide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine	Olanzapine The serum concentration of Propranolol can be increased when it is combined with Olanzapine.
Alosetron	Alosetron The metabolism of Propranolol can be decreased when combined with Alosetron.
Dofetilide	Dofetilide Propranolol may increase the arrhythmogenic activities of Dofetilide.
Entacapone	Entacapone The metabolism of Propranolol can be decreased when combined with Entacapone.
Eprosartan	Eprosartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Eprosartan.
Hydroxychloroquine	Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Propranolol.
Meloxicam	Meloxicam Meloxicam may decrease the antihypertensive activities of Propranolol.
Oxcarbazepine	Oxcarbazepine The serum concentration of Propranolol can be increased when it is combined with Oxcarbazepine.
Pantoprazole	Pantoprazole The serum concentration of Propranolol can be increased when it is combined with Pantoprazole.
Sevelamer	Sevelamer Sevelamer can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan	Telmisartan The serum concentration of Propranolol can be increased when it is combined with Telmisartan.
Temozolomide	Temozolomide Propranolol may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon	Zaleplon Propranolol may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra	Anakinra The metabolism of Propranolol can be increased when combined with Anakinra.
Desloratadine	Desloratadine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Desloratadine.
Linezolid	Linezolid Linezolid may increase the hypotensive activities of Propranolol.
Rivastigmine	Rivastigmine Propranolol may increase the bradycardic activities of Rivastigmine.
Trimipramine	Trimipramine The metabolism of Propranolol can be decreased when combined with Trimipramine.
Etanercept Injection	Etanercept Injection The metabolism of Propranolol can be increased when combined with Etanercept.
Modafinil	Modafinil The serum concentration of Propranolol can be increased when it is combined with Modafinil.
Perindopril	Perindopril Propranolol may increase the hypotensive activities of Perindopril.
Tenofovir	Tenofovir Tenofovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Propranolol.
Sirolimus	Sirolimus The metabolism of Sirolimus can be decreased when combined with Propranolol.
Dutasteride	Dutasteride The metabolism of Dutasteride can be decreased when combined with Propranolol.
Epinephrine Injection	Epinephrine Injection Propranolol may decrease the bronchodilatory activities of Epinephrine.
Eplerenone	Eplerenone Propranolol may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram	Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Propranolol.
Olmesartan	Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Propranolol.
Zonisamide	Zonisamide The serum concentration of Propranolol can be increased when it is combined with Zonisamide.
Adalimumab Injection	Adalimumab Injection The metabolism of Propranolol can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Propranolol.
Atomoxetine	Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Propranolol.
Dexmethylphenidate	Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Propranolol.
Atazanavir	Atazanavir Atazanavir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Almotriptan	Almotriptan The metabolism of Almotriptan can be decreased when combined with Propranolol.
Eletriptan	Eletriptan The metabolism of Eletriptan can be decreased when combined with Propranolol.
Mefloquine	Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Propranolol.
Rosuvastatin	Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Propranolol.
Vardenafil	Vardenafil The risk or severity of QTc prolongation can be increased when Propranolol is combined with Vardenafil.
Alfuzosin	Alfuzosin Alfuzosin may increase the hypotensive activities of Propranolol.
Aprepitant	Aprepitant The serum concentration of Propranolol can be increased when it is combined with Aprepitant.
Emtricitabine	Emtricitabine Propranolol may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection	Interferon Beta-1a Subcutaneous Injection The metabolism of Propranolol can be decreased when combined with Interferon beta-1a.
Memantine	Memantine The serum concentration of Propranolol can be increased when it is combined with Memantine.
Tegaserod	Tegaserod The metabolism of Propranolol can be decreased when combined with Tegaserod.
Tadalafil	Tadalafil Propranolol may increase the antihypertensive activities of Tadalafil.
Frovatriptan	Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Propranolol.
Gemifloxacin	Gemifloxacin The risk or severity of QTc prolongation can be increased when Propranolol is combined with Gemifloxacin.
Progesterone	Progesterone The serum concentration of Propranolol can be increased when it is combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Propranolol.
Infliximab Injection	Infliximab Injection The metabolism of Propranolol can be increased when combined with Infliximab.
Protriptyline	Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Propranolol.
Rifaximin	Rifaximin The serum concentration of Propranolol can be decreased when it is combined with Rifaximin.
Duloxetine	Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Propranolol is combined with Duloxetine.
Norethindrone	Norethindrone The metabolism of Propranolol can be decreased when combined with Norethisterone.
Tinidazole	Tinidazole Propranolol may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium	Trospium The metabolism of Propranolol can be decreased when combined with Trospium.
Bosentan	Bosentan Bosentan may increase the hypotensive activities of Propranolol.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cinacalcet	Cinacalcet The metabolism of Propranolol can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Erlotinib	Erlotinib The metabolism of Erlotinib can be decreased when combined with Propranolol.
Eszopiclone	Eszopiclone Eszopiclone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ganciclovir	Ganciclovir Propranolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection	Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin aspart.
Ribavirin	Ribavirin Propranolol may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin	Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Propranolol.
Valganciclovir	Valganciclovir Propranolol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole	Voriconazole The serum concentration of Propranolol can be increased when it is combined with Voriconazole.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Amphetamine.
Entecavir	Entecavir The metabolism of Propranolol can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection	Peginterferon Alfa-2a Injection The metabolism of Propranolol can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Propranolol can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection	Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Propranolol.
Exenatide Injection	Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Propranolol.
Ibandronate	Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Propranolol.
Isocarboxazid	Isocarboxazid Isocarboxazid may increase the hypotensive activities of Propranolol.
Ramelteon	Ramelteon The metabolism of Ramelteon can be decreased when combined with Propranolol.
Darifenacin	Darifenacin The metabolism of Darifenacin can be decreased when combined with Propranolol.
Fentanyl	Fentanyl Fentanyl may decrease the antihypertensive activities of Propranolol.
Pregabalin	Pregabalin Pregabalin may increase the arrhythmogenic activities of Propranolol.
Deferasirox	Deferasirox The serum concentration of Propranolol can be increased when it is combined with Deferasirox.
Phenylephrine	Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Propranolol.
Tipranavir	Tipranavir The serum concentration of Propranolol can be increased when it is combined with Tipranavir.
Felbamate	Felbamate The serum concentration of Propranolol can be increased when it is combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection	Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin detemir.
Ranolazine	Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Propranolol.
Abatacept Injection	Abatacept Injection The metabolism of Propranolol can be increased when combined with Abatacept.
Rasagiline	Rasagiline Rasagiline may increase the hypotensive activities of Propranolol.
Imatinib	Imatinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Imatinib.
Sitagliptin	Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Propranolol.
Varenicline	Varenicline The excretion of Varenicline can be decreased when combined with Propranolol.
Gefitinib	Gefitinib The serum concentration of Propranolol can be increased when it is combined with Gefitinib.
Albuterol	Albuterol Propranolol may decrease the bronchodilatory activities of Salbutamol.
Paliperidone	Paliperidone The risk or severity of QTc prolongation can be increased when Propranolol is combined with Paliperidone.
Bortezomib	Bortezomib The serum concentration of Propranolol can be increased when it is combined with Bortezomib.
Clofarabine Injection	Clofarabine Injection The serum concentration of Clofarabine can be increased when it is combined with Propranolol.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glulisine.
Lubiprostone	Lubiprostone Propranolol may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection	Oxaliplatin Injection The serum concentration of Oxaliplatin can be increased when it is combined with Propranolol.
Posaconazole	Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Propranolol.
Primaquine	Primaquine The metabolism of Propranolol can be decreased when combined with Primaquine.
Rituximab Injection	Rituximab Injection Propranolol may increase the hypotensive activities of Rituximab.
Aliskiren	Aliskiren The risk or severity of hyperkalemia can be increased when Propranolol is combined with Aliskiren.
Pemetrexed Injection	Pemetrexed Injection Propranolol may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate	Dimenhydrinate The risk or severity of QTc prolongation can be increased when Propranolol is combined with Dimenhydrinate.
Lisdexamfetamine	Lisdexamfetamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Lisdexamfetamine.
Nabilone	Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Propranolol.
Vorinostat	Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Propranolol.
Sorafenib	Sorafenib The serum concentration of Propranolol can be increased when it is combined with Sorafenib.
Sunitinib	Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Propranolol.
Lapatinib	Lapatinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Lapatinib.
Levocetirizine	Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Propranolol.
Pegaptanib Injection	Pegaptanib Injection Propranolol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The metabolism of Dasatinib can be decreased when combined with Propranolol.
Mexiletine	Mexiletine Mexiletine may increase the arrhythmogenic activities of Propranolol.
Armodafinil	Armodafinil The serum concentration of Propranolol can be increased when it is combined with Armodafinil.
Azacitidine Injection	Azacitidine Injection Propranolol may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Temsirolimus	Temsirolimus The metabolism of Propranolol can be decreased when combined with Temsirolimus.
Lenalidomide	Lenalidomide Lenalidomide may decrease the excretion rate of Propranolol which could result in a higher serum level.
Nilotinib	Nilotinib The metabolism of Nilotinib can be decreased when combined with Propranolol.
Toremifene	Toremifene The risk or severity of QTc prolongation can be increased when Propranolol is combined with Toremifene.
Budesonide	Budesonide The metabolism of Propranolol can be increased when combined with Budesonide.
Chloramphenicol Injection	Chloramphenicol Injection The serum concentration of Propranolol can be increased when it is combined with Chloramphenicol.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Betaine	Betaine Glycine betaine may increase the bradycardic activities of Propranolol.
Doripenem Injection	Doripenem Injection Propranolol may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine	Etravirine The serum concentration of Propranolol can be increased when it is combined with Etravirine.
Arsenic Trioxide Injection	Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Arsenic trioxide.
Desvenlafaxine	Desvenlafaxine The serum concentration of Propranolol can be increased when it is combined with Desvenlafaxine.
Cevimeline	Cevimeline The risk or severity of adverse effects can be increased when Cevimeline is combined with Propranolol.
Nebivolol	Nebivolol Propranolol may increase the arrhythmogenic activities of Nebivolol.
Tretinoin	Tretinoin The metabolism of Tretinoin can be decreased when combined with Propranolol.
Bendamustine Injection	Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Propranolol.
Pilocarpine	Pilocarpine The risk or severity of adverse effects can be increased when Propranolol is combined with Pilocarpine.
Flecainide	Flecainide Propranolol may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection	Certolizumab Injection The metabolism of Propranolol can be increased when combined with Certolizumab pegol.
Irinotecan Injection	Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Propranolol.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Praziquantel	Praziquantel The metabolism of Praziquantel can be decreased when combined with Propranolol.
Methylnaltrexone Injection	Methylnaltrexone Injection Propranolol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Silodosin	Silodosin Propranolol may increase the orthostatic hypotensive activities of Silodosin.
Midazolam	Midazolam Propranolol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection	Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Propranolol which could result in a higher serum level.
Eltrombopag	Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Propranolol.
Milnacipran	Milnacipran The serum concentration of Propranolol can be increased when it is combined with Milnacipran.
Dexlansoprazole	Dexlansoprazole The metabolism of Propranolol can be decreased when combined with Dexlansoprazole.
Plerixafor Injection	Plerixafor Injection Propranolol may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate	Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Propranolol.
Fesoterodine	Fesoterodine Propranolol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Degarelix Injection	Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Propranolol.
Betaxolol	Betaxolol Betaxolol may increase the arrhythmogenic activities of Propranolol.
Iloperidone	Iloperidone The risk or severity of QTc prolongation can be increased when Propranolol is combined with Iloperidone.
Prasugrel	Prasugrel Propranolol may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide	Lacosamide The metabolism of Lacosamide can be decreased when combined with Propranolol.
Everolimus	Everolimus The metabolism of Propranolol can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone	Dronedarone Dronedarone may increase the bradycardic activities of Propranolol.
Pralatrexate Injection	Pralatrexate Injection Propranolol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection Palonosetron may decrease the excretion rate of Propranolol which could result in a higher serum level.
Saxagliptin	Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Propranolol.
Telavancin Injection	Telavancin Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Telavancin.
Romidepsin Injection	Romidepsin Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Romidepsin.
Tapentadol	Tapentadol The metabolism of Propranolol can be decreased when combined with Tapentadol.
Topotecan	Topotecan Propranolol may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection	Golimumab Injection The metabolism of Propranolol can be increased when combined with Golimumab.
Pazopanib	Pazopanib The metabolism of Pazopanib can be decreased when combined with Propranolol.
Asenapine	Asenapine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Asenapine.
Albendazole	Albendazole The metabolism of Propranolol can be decreased when combined with Albendazole.
Levonorgestrel	Levonorgestrel The metabolism of Propranolol can be decreased when combined with Levonorgestrel.
Oxymorphone	Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Propranolol.
Liraglutide Injection	Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Propranolol.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Propranolol can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine The serum concentration of Dalfampridine can be increased when it is combined with Propranolol.
Fingolimod	Fingolimod Propranolol may increase the bradycardic activities of Fingolimod.
Eribulin Injection	Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Propranolol.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Propranolol.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Lurasidone	Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Propranolol.
Acetaminophen Injection	Acetaminophen Injection The metabolism of Propranolol can be decreased when combined with Acetaminophen.
Vilazodone	Vilazodone The metabolism of Propranolol can be decreased when combined with Vilazodone.
Ipilimumab Injection	Ipilimumab Injection Propranolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Terbutaline Injection	Terbutaline Injection Propranolol may decrease the bronchodilatory activities of Terbutaline.
Azilsartan	Azilsartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Azilsartan medoxomil.
Roflumilast	Roflumilast Propranolol may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin	Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Propranolol.
Rilpivirine	Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Propranolol.
Potassium Iodide	Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Propranolol.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Propranolol can be decreased when combined with Cyclophosphamide.
Abiraterone	Abiraterone The serum concentration of Propranolol can be increased when it is combined with Abiraterone.
Triptorelin Injection	Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Propranolol.
Rivaroxaban	Rivaroxaban Propranolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib	Ruxolitinib Ruxolitinib may increase the bradycardic activities of Propranolol.
Vandetanib	Vandetanib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Vandetanib.
Clobazam	Clobazam The metabolism of Propranolol can be decreased when combined with Clobazam.
Vemurafenib	Vemurafenib The serum concentration of Propranolol can be increased when it is combined with Vemurafenib.
Vismodegib	Vismodegib The serum concentration of Propranolol can be increased when it is combined with Vismodegib.
Ivacaftor	Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Propranolol.
Deferiprone	Deferiprone Propranolol may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Propranolol.
Crizotinib	Crizotinib The metabolism of Propranolol can be decreased when combined with Crizotinib.
Cabergoline	Cabergoline Propranolol may increase the vasoconstricting activities of Cabergoline.
Naloxone Injection	Naloxone Injection Propranolol may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan	Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Propranolol.
Fondaparinux Injection	Fondaparinux Injection Fondaparinux may decrease the excretion rate of Propranolol which could result in a higher serum level.
Iloprost	Iloprost Iloprost may increase the hypotensive activities of Propranolol.
Enzalutamide	Enzalutamide The serum concentration of Propranolol can be decreased when it is combined with Enzalutamide.
Mirabegron	Mirabegron The metabolism of Mirabegron can be decreased when combined with Propranolol.
Regorafenib	Regorafenib Regorafenib may increase the bradycardic activities of Propranolol.
Teriflunomide	Teriflunomide The serum concentration of Propranolol can be decreased when it is combined with Teriflunomide.
Lorcaserin	Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Propranolol.
Teduglutide Injection	Teduglutide Injection Propranolol may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline	Bedaquiline The risk or severity of QTc prolongation can be increased when Propranolol is combined with Bedaquiline.
Tofacitinib	Tofacitinib Propranolol may increase the bradycardic activities of Tofacitinib.
Alogliptin	Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Propranolol.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Propranolol.
Pomalidomide	Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Propranolol.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Propranolol.
Apixaban	Apixaban The metabolism of Apixaban can be decreased when combined with Propranolol.
Canagliflozin	Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Propranolol.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib	Dabrafenib The serum concentration of Dabrafenib can be decreased when it is combined with Propranolol.
Ospemifene	Ospemifene The metabolism of Propranolol can be decreased when combined with Ospemifene.
Trametinib	Trametinib Propranolol may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran	Levomilnacipran The serum concentration of Propranolol can be increased when it is combined with Levomilnacipran.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Propranolol which could result in a higher serum level.
Vortioxetine	Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Propranolol.
Perampanel	Perampanel The metabolism of Perampanel can be decreased when combined with Propranolol.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Propranolol.
Avanafil	Avanafil Avanafil may increase the antihypertensive activities of Propranolol.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Propranolol.
Obinutuzumab Injection	Obinutuzumab Injection Propranolol may increase the hypotensive activities of Obinutuzumab.
Simeprevir	Simeprevir The metabolism of Propranolol can be decreased when combined with Simeprevir.
Sofosbuvir	Sofosbuvir Propranolol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin The therapeutic efficacy of Propranolol can be increased when used in combination with Dapagliflozin.
Apremilast	Apremilast The metabolism of Propranolol can be increased when combined with Apremilast.
Droxidopa	Droxidopa Propranolol may decrease the bronchodilatory activities of Droxidopa.
Ceritinib	Ceritinib Propranolol may increase the bradycardic activities of Ceritinib.
Siltuximab Injection	Siltuximab Injection The metabolism of Propranolol can be increased when combined with Siltuximab.
Albiglutide Injection	Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Propranolol.
Eslicarbazepine	Eslicarbazepine The serum concentration of Propranolol can be increased when it is combined with Eslicarbazepine.
Belinostat Injection	Belinostat Injection The metabolism of Propranolol can be increased when combined with Belinostat.
Testosterone Injection	Testosterone Injection Testosterone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Oritavancin Injection	Oritavancin Injection The serum concentration of Propranolol can be increased when it is combined with Oritavancin.
Empagliflozin	Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Propranolol.
Hydrocodone	Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Propranolol.
Dulaglutide Injection	Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Propranolol.
Edoxaban	Edoxaban Propranolol may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Peginterferon Beta-1a Injection	Peginterferon Beta-1a Injection The metabolism of Propranolol can be decreased when combined with Peginterferon beta-1a.
Olaparib	Olaparib The metabolism of Olaparib can be decreased when combined with Propranolol.
Methamphetamine	Methamphetamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Metamfetamine.
Tasimelteon	Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Propranolol.
Riociguat	Riociguat Propranolol may increase the hypotensive activities of Riociguat.
Lanreotide Injection	Lanreotide Injection Propranolol may increase the bradycardic activities of Lanreotide.
Pirfenidone	Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Propranolol.
Secukinumab Injection	Secukinumab Injection The metabolism of Propranolol can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection Propranolol may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation	Insulin Human Inhalation The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin human.
Lenvatinib	Lenvatinib The serum concentration of Propranolol can be increased when it is combined with Lenvatinib.
Naloxegol	Naloxegol The serum concentration of Propranolol can be increased when it is combined with Naloxegol.
Panobinostat	Panobinostat The metabolism of Propranolol can be decreased when combined with Panobinostat.
Dinutuximab Injection	Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Propranolol.
Haloperidol Injection	Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Propranolol.
Ivabradine	Ivabradine Propranolol may increase the bradycardic activities of Ivabradine.
Amiloride	Amiloride Propranolol may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan	Macitentan Propranolol may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin	Flibanserin Flibanserin may decrease the antihypertensive activities of Propranolol.
Rolapitant	Rolapitant The metabolism of Propranolol can be decreased when combined with Rolapitant.
Daclatasvir	Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Propranolol.
Brexpiprazole	Brexpiprazole Propranolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ziprasidone.
Cariprazine	Cariprazine Cariprazine may decrease the antihypertensive activities of Propranolol.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Propranolol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin degludec.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Propranolol.
Osimertinib	Osimertinib The serum concentration of Propranolol can be decreased when it is combined with Osimertinib.
Ixazomib	Ixazomib Propranolol may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Rifapentine	Rifapentine The serum concentration of Propranolol can be decreased when it is combined with Rifapentine.
Lesinurad	Lesinurad Propranolol may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dexamethasone Injection	Dexamethasone Injection The serum concentration of Propranolol can be decreased when it is combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection Propranolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Cobicistat	Cobicistat The metabolism of Propranolol can be decreased when combined with Cobicistat.
Midodrine	Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Propranolol.
Selexipag	Selexipag Propranolol may increase the hypotensive activities of Selexipag.
Obeticholic Acid	Obeticholic Acid The metabolism of Propranolol can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection	Diphenhydramine Injection The metabolism of Propranolol can be decreased when combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection Propranolol may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib	Rucaparib The serum concentration of Propranolol can be increased when it is combined with Rucaparib.
Lixisenatide Injection	Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Propranolol.
Ribociclib	Ribociclib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ribociclib.
Doxepin (Insomnia)	Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Propranolol.
Deutetrabenazine	Deutetrabenazine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Deutetrabenazine.
Valbenazine	Valbenazine Propranolol may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort	Deflazacort The metabolism of Propranolol can be increased when combined with Deflazacort.
Safinamide	Safinamide The serum concentration of Propranolol can be increased when it is combined with Safinamide.
Naldemedine	Naldemedine Propranolol may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin	Midostaurin The serum concentration of Propranolol can be decreased when it is combined with Midostaurin.
Enasidenib	Enasidenib The serum concentration of Propranolol can be increased when it is combined with Enasidenib.
Benznidazole	Benznidazole Propranolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection	Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Propranolol.
Delafloxacin	Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Propranolol.
Acalabrutinib	Acalabrutinib The metabolism of Propranolol can be decreased when combined with Acalabrutinib.
Letermovir	Letermovir The serum concentration of Propranolol can be decreased when it is combined with Letermovir.
Semaglutide Injection	Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Propranolol.
Tetrabenazine	Tetrabenazine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Propranolol.
Buprenorphine Injection	Buprenorphine Injection The serum concentration of Propranolol can be increased when it is combined with Buprenorphine.
Apalutamide	Apalutamide The serum concentration of Propranolol can be increased when it is combined with Apalutamide.
Fostamatinib	Fostamatinib Fostamatinib may increase the antihypertensive activities of Propranolol.
Baricitinib	Baricitinib Propranolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine	Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Propranolol.
Plazomicin Injection	Plazomicin Injection Propranolol may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat	Eliglustat The risk or severity of QTc prolongation can be increased when Propranolol is combined with Eliglustat.
Encorafenib	Encorafenib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Encorafenib.
Binimetinib	Binimetinib The metabolism of Binimetinib can be decreased when combined with Propranolol.
Ivosidenib	Ivosidenib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ivosidenib.
Elagolix	Elagolix The metabolism of Elagolix can be decreased when combined with Propranolol.
Eravacycline Injection	Eravacycline Injection The metabolism of Eravacycline can be decreased when combined with Propranolol.
Doravirine	Doravirine The metabolism of Doravirine can be decreased when combined with Propranolol.
Tafenoquine	Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Propranolol.
Cannabidiol	Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Propranolol.
Dacomitinib	Dacomitinib The metabolism of Propranolol can be decreased when combined with Dacomitinib.
Stiripentol	Stiripentol The serum concentration of Propranolol can be increased when it is combined with Stiripentol.
Gilteritinib	Gilteritinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Gilteritinib.
Glasdegib	Glasdegib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Glasdegib.
Lorlatinib	Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Propranolol.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Propranolol.
Rifamycin	Rifamycin The serum concentration of Propranolol can be decreased when it is combined with Rifamycin.
Prucalopride	Prucalopride Propranolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Propranolol can be increased when combined with Emapalumab.
Siponimod	Siponimod Siponimod may decrease the antihypertensive activities of Propranolol.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Esomeprazole Injection	Esomeprazole Injection The serum concentration of Propranolol can be increased when it is combined with Esomeprazole.
Alpelisib	Alpelisib The metabolism of Propranolol can be decreased when combined with Alpelisib.
Solriamfetol	Solriamfetol The serum concentration of Solriamfetol can be increased when it is combined with Propranolol.
Triclabendazole	Triclabendazole The metabolism of Propranolol can be decreased when combined with Triclabendazole.
Entrectinib	Entrectinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Entrectinib.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Propranolol.
Pitolisant	Pitolisant The serum concentration of Propranolol can be decreased when it is combined with Pitolisant.
Fedratinib	Fedratinib The metabolism of Fedratinib can be decreased when combined with Propranolol.
Lefamulin	Lefamulin Propranolol may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection	Phenytoin Injection The serum concentration of Propranolol can be decreased when it is combined with Phenytoin.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Propranolol can be increased when combined with Fosphenytoin.
Voxelotor	Voxelotor The metabolism of Voxelotor can be decreased when combined with Propranolol.
Lasmiditan	Lasmiditan Lasmiditan may increase the bradycardic activities of Propranolol.
Calcium Acetate	Calcium Acetate The therapeutic efficacy of Propranolol can be decreased when used in combination with Calcium acetate.
Cenobamate	Cenobamate The serum concentration of Propranolol can be decreased when it is combined with Cenobamate.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Propranolol.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Propranolol.
Selpercatinib	Selpercatinib Selpercatinib may decrease the antihypertensive activities of Propranolol.
Capmatinib	Capmatinib The metabolism of Propranolol can be decreased when combined with Capmatinib.
Lemborexant	Lemborexant The metabolism of Lemborexant can be decreased when combined with Propranolol.
Fenfluramine	Fenfluramine The metabolism of Propranolol can be decreased when combined with Fenfluramine.
Fostemsavir	Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Propranolol.
Octreotide	Octreotide The serum concentration of the active metabolites of Propranolol can be increased when Propranolol is used in combination with Octreotide.
Pralsetinib	Pralsetinib The metabolism of Propranolol can be decreased when combined with Pralsetinib.
Opicapone	Opicapone The serum concentration of Propranolol can be decreased when it is combined with Opicapone.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Propranolol can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection	Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Propranolol.
Relugolix	Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Propranolol.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Propranolol may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine	Viloxazine Propranolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Theophylline	Theophylline The metabolism of Propranolol can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen Fenoprofen may decrease the antihypertensive activities of Propranolol.
Indomethacin	Indomethacin The serum concentration of Propranolol can be increased when it is combined with Indomethacin.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Propranolol.
Naproxen	Naproxen Naproxen may decrease the antihypertensive activities of Propranolol.
Tolmetin	Tolmetin Tolmetin may decrease the antihypertensive activities of Propranolol.
Sulindac	Sulindac Sulindac may decrease the antihypertensive activities of Propranolol.
Trazodone	Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Propranolol.
Isotretinoin	Isotretinoin Propranolol may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate	Sucralfate Sucralfate may decrease the excretion rate of Propranolol which could result in a higher serum level.
Hydroxyurea	Hydroxyurea The metabolism of Propranolol can be decreased when combined with Hydroxyurea.
Floxuridine	Floxuridine Floxuridine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Phenobarbital	Phenobarbital The serum concentration of Propranolol can be decreased when it is combined with Phenobarbital.
Metaxalone	Metaxalone Propranolol may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection	Methotrexate Injection Methotrexate may decrease the excretion rate of Propranolol which could result in a higher serum level.
Primidone	Primidone The serum concentration of Propranolol can be decreased when it is combined with Primidone.
Methsuximide	Methsuximide The serum concentration of Propranolol can be increased when it is combined with Methsuximide.
Diethylpropion	Diethylpropion The therapeutic efficacy of Propranolol can be decreased when used in combination with Diethylpropion.
Chlorpromazine	Chlorpromazine The metabolism of Propranolol can be decreased when combined with Chlorpromazine.
Diazepam	Diazepam The serum concentration of Propranolol can be increased when it is combined with Diazepam.
Oxazepam	Oxazepam Propranolol may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam	Flurazepam Propranolol may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate	Clorazepate Propranolol may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Phenoxybenzamine	Phenoxybenzamine Propranolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Carmustine	Carmustine The metabolism of Propranolol can be decreased when combined with Carmustine.
Amantadine	Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Propranolol.
Codeine	Codeine Codeine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Bromocriptine	Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Propranolol.
Metaproterenol	Metaproterenol Propranolol may decrease the bronchodilatory activities of Orciprenaline.
Tranylcypromine	Tranylcypromine The serum concentration of Propranolol can be increased when it is combined with Tranylcypromine.
Phenelzine	Phenelzine The serum concentration of Propranolol can be increased when it is combined with Phenelzine.
Procarbazine	Procarbazine Procarbazine may increase the hypotensive activities of Propranolol.
Ergoloid Mesylates	Ergoloid Mesylates Propranolol may increase the vasoconstricting activities of Ergoloid mesylate.
Tetracycline	Tetracycline Propranolol may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Prochlorperazine	Prochlorperazine The serum concentration of Propranolol can be increased when it is combined with Prochlorperazine.
Thioridazine	Thioridazine The serum concentration of Thioridazine can be increased when it is combined with Propranolol.
Trifluoperazine	Trifluoperazine The serum concentration of Propranolol can be increased when it is combined with Trifluoperazine.
Bleomycin	Bleomycin Bleomycin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dapsone	Dapsone The metabolism of Propranolol can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine The therapeutic efficacy of Propranolol can be increased when used in combination with Sulfadiazine.
Oxycodone	Oxycodone The metabolism of Propranolol can be decreased when combined with Oxycodone.
Methadone	Methadone The metabolism of Propranolol can be decreased when combined with Methadone.
Oxybutynin	Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Propranolol.
Benztropine	Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Propranolol.
Colestipol	Colestipol Colestipol can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline	Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Propranolol.
Ibuprofen	Ibuprofen Ibuprofen may decrease the antihypertensive activities of Propranolol.
Orphenadrine	Orphenadrine The metabolism of Propranolol can be decreased when combined with Orphenadrine.
Perphenazine	Perphenazine The serum concentration of Propranolol can be increased when it is combined with Perphenazine.
Azathioprine	Azathioprine The metabolism of Azathioprine can be decreased when combined with Propranolol.
Fluphenazine	Fluphenazine The serum concentration of Propranolol can be increased when it is combined with Fluphenazine.
Phentermine	Phentermine The therapeutic efficacy of Propranolol can be decreased when used in combination with Phentermine.
Methylphenidate	Methylphenidate Methylphenidate may decrease the antihypertensive activities of Propranolol.
Amoxapine	Amoxapine The metabolism of Propranolol can be decreased when combined with Amoxapine.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Propranolol.
Hydrocortisone	Hydrocortisone The serum concentration of Hydrocortisone can be decreased when it is combined with Propranolol.
Doxorubicin	Doxorubicin The metabolism of Propranolol can be decreased when combined with Doxorubicin.
Mechlorethamine	Mechlorethamine Mechlorethamine may increase the bradycardic activities of Propranolol.
Pyridostigmine	Pyridostigmine Pyridostigmine may increase the bradycardic activities of Propranolol.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Carbamazepine	Carbamazepine The serum concentration of Propranolol can be decreased when it is combined with Carbamazepine.
Methyldopa	Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Propranolol.
Clonidine	Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Propranolol.
Prazosin	Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Propranolol.
Hydralazine	Hydralazine Propranolol may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine	Cimetidine The serum concentration of Propranolol can be increased when it is combined with Cimetidine.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Warfarin	Warfarin The serum concentration of Propranolol can be increased when it is combined with Warfarin.
Clonazepam	Clonazepam Propranolol may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide	Loperamide The risk or severity of bradycardia can be increased when Propranolol is combined with Loperamide.
Promethazine	Promethazine The serum concentration of Propranolol can be increased when it is combined with Promethazine.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Propranolol.
Daunorubicin	Daunorubicin The metabolism of Propranolol can be increased when combined with Daunorubicin.
Nitrofurantoin	Nitrofurantoin The risk or severity of hyperkalemia can be increased when Propranolol is combined with Nitrofurantoin.
Griseofulvin	Griseofulvin The metabolism of Propranolol can be increased when combined with Griseofulvin.
Digoxin	Digoxin Propranolol may increase the arrhythmogenic activities of Digoxin.
Chloroquine	Chloroquine The metabolism of Propranolol can be decreased when combined with Chloroquine.
Quinine	Quinine The serum concentration of Propranolol can be increased when it is combined with Quinine.
Ethosuximide	Ethosuximide The risk or severity of bradycardia can be increased when Ethosuximide is combined with Propranolol.
Triamterene	Triamterene The metabolism of Propranolol can be decreased when combined with Triamterene.
Chlorothiazide	Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Propranolol.
Chlorthalidone	Chlorthalidone Chlorthalidone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone	Metolazone Metolazone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection	Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Propranolol.
Secobarbital	Secobarbital The serum concentration of Propranolol can be decreased when it is combined with Secobarbital.
Desipramine	Desipramine The metabolism of Propranolol can be decreased when combined with Desipramine.
Amitriptyline	Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Propranolol.
Imipramine	Imipramine The serum concentration of Propranolol can be increased when it is combined with Imipramine.
Probenecid	Probenecid The serum concentration of Propranolol can be increased when it is combined with Probenecid.
Quinidine	Quinidine The serum concentration of Propranolol can be increased when it is combined with Quinidine.
Procainamide	Procainamide Propranolol may increase the arrhythmogenic activities of Procainamide.
Isoniazid	Isoniazid The serum concentration of Propranolol can be increased when it is combined with Isoniazid.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Propranolol which could result in a higher serum level.
Rifampin	Rifampin The serum concentration of Propranolol can be decreased when it is combined with Rifampicin.
Disopyramide	Disopyramide Disopyramide may increase the bradycardic activities of Propranolol.
Valproic Acid	Valproic Acid The serum concentration of Propranolol can be increased when it is combined with Valproic acid.
Tamoxifen	Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Propranolol.
Butabarbital	Butabarbital Butabarbital may increase the hypotensive activities of Propranolol.
Levothyroxine	Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Propranolol.
Liothyronine	Liothyronine The therapeutic efficacy of Propranolol can be decreased when used in combination with Liothyronine.
Methimazole	Methimazole The excretion of Propranolol can be decreased when combined with Methimazole.
Chlorpropamide	Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Propranolol.
Glucagon Injection	Glucagon Injection The therapeutic efficacy of Propranolol can be decreased when used in combination with Glucagon.
Tolbutamide	Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Propranolol.
Tolazamide	Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Propranolol.
Dextromethorphan	Dextromethorphan The metabolism of Propranolol can be decreased when combined with Dextromethorphan.
Cyclobenzaprine	Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Propranolol.
Niacin	Niacin The metabolism of Propranolol can be decreased when combined with Niacin.
Baclofen	Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Propranolol.
Doxylamine	Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Propranolol.
Cyproheptadine	Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Propranolol.
Clemastine	Clemastine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Clemastine.
Chlorpheniramine	Chlorpheniramine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Propranolol.
Meclizine	Meclizine The metabolism of Meclizine can be decreased when combined with Propranolol.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Propranolol which could result in a higher serum level.
Methyclothiazide	Methyclothiazide The therapeutic efficacy of Propranolol can be increased when used in combination with Methyclothiazide.
Dantrolene	Dantrolene The risk or severity of hyperkalemia can be increased when Propranolol is combined with Dantrolene.
Chlorzoxazone	Chlorzoxazone The metabolism of Propranolol can be decreased when combined with Chlorzoxazone.
Carisoprodol	Carisoprodol The metabolism of Propranolol can be decreased when combined with Carisoprodol.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Disulfiram	Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Propranolol.
Minoxidil	Minoxidil Minoxidil may increase the hypotensive activities of Propranolol.
Pseudoephedrine	Pseudoephedrine The therapeutic efficacy of Propranolol can be decreased when used in combination with Pseudoephedrine.
Nortriptyline	Nortriptyline The metabolism of Propranolol can be decreased when combined with Nortriptyline.
Spironolactone	Spironolactone Spironolactone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection	Amphotericin B Injection Amphotericin B may decrease the excretion rate of Propranolol which could result in a higher serum level.
Mercaptopurine	Mercaptopurine The risk or severity of adverse effects can be increased when Propranolol is combined with Mercaptopurine.
Phytonadione	Phytonadione Propranolol may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Nadolol	Nadolol Propranolol may increase the arrhythmogenic activities of Nadolol.
Cholestyramine Resin	Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol	Allopurinol Allopurinol may decrease the excretion rate of Propranolol which could result in a higher serum level.
Oxytocin Injection	Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Propranolol.
Flavoxate	Flavoxate Propranolol may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine	Papaverine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Papaverine.
Fluorouracil Injection	Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Propranolol.
Colchicine	Colchicine Propranolol may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dacarbazine	Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Propranolol.
Acetazolamide	Acetazolamide Acetazolamide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ketoconazole	Ketoconazole The serum concentration of Propranolol can be increased when it is combined with Ketoconazole.
Pyrantel	Pyrantel Propranolol may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection	Thiotepa Injection Thiotepa may increase the bradycardic activities of Propranolol.
Vincristine Injection	Vincristine Injection The metabolism of Propranolol can be decreased when combined with Vincristine.
Captopril	Captopril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Captopril.
Dipyridamole	Dipyridamole Dipyridamole may increase the bradycardic activities of Propranolol.
Isoxsuprine	Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Propranolol.
Vinblastine	Vinblastine The metabolism of Propranolol can be decreased when combined with Vinblastine.
Bethanechol	Bethanechol The risk or severity of adverse effects can be increased when Propranolol is combined with Bethanechol.
Ethacrynic Acid	Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Propranolol which could result in a higher serum level.
Metoprolol	Metoprolol The metabolism of Propranolol can be decreased when combined with Metoprolol.
Hydroxyzine	Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Propranolol.
Thiothixene	Thiothixene The metabolism of Thiothixene can be decreased when combined with Propranolol.
Aspirin	Aspirin The serum concentration of Propranolol can be decreased when it is combined with Acetylsalicylic acid.
Salsalate	Salsalate Salsalate may decrease the antihypertensive activities of Propranolol.
Alprazolam	Alprazolam Alprazolam may decrease the excretion rate of Propranolol which could result in a higher serum level.
Temazepam	Temazepam Temazepam may decrease the excretion rate of Propranolol which could result in a higher serum level.
Triazolam	Triazolam Propranolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine	Dicyclomine Propranolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine	Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Propranolol.
Propantheline	Propantheline Propranolol may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim	Trimethoprim Trimethoprim may decrease the excretion rate of Propranolol which could result in a higher serum level.
Diltiazem	Diltiazem The risk or severity of bradycardia can be increased when Diltiazem is combined with Propranolol.
Nifedipine	Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Propranolol.
Timolol	Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Propranolol.
Verapamil	Verapamil The risk or severity of adverse effects can be increased when Propranolol is combined with Verapamil.
Atenolol	Atenolol Atenolol may increase the arrhythmogenic activities of Propranolol.
Pindolol	Pindolol The risk or severity of hyperkalemia can be increased when Propranolol is combined with Pindolol.
Cisplatin Injection	Cisplatin Injection The serum concentration of Cisplatin can be increased when it is combined with Propranolol.
Diflunisal	Diflunisal Diflunisal may decrease the antihypertensive activities of Propranolol.
Piroxicam	Piroxicam Piroxicam may decrease the antihypertensive activities of Propranolol.
Bumetanide	Bumetanide Propranolol may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin	Streptozocin The metabolism of Propranolol can be increased when combined with Streptozocin.
Etoposide	Etoposide The metabolism of Etoposide can be decreased when combined with Propranolol.
Glyburide	Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Propranolol.
Glipizide	Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Propranolol.
Indapamide	Indapamide The therapeutic efficacy of Propranolol can be increased when used in combination with Indapamide.
Amoxicillin	Amoxicillin Propranolol may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection	Nafcillin Injection The metabolism of Propranolol can be increased when combined with Nafcillin.
Oxacillin Injection	Oxacillin Injection Propranolol may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline	Pentoxifylline Pentoxifylline may increase the hypotensive activities of Propranolol.
Pentamidine Injection	Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Propranolol.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Labetalol	Labetalol Propranolol may increase the orthostatic hypotensive activities of Labetalol.
Auranofin	Auranofin Propranolol may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propranolol.
Gemfibrozil	Gemfibrozil The serum concentration of Propranolol can be increased when it is combined with Gemfibrozil.
Guanabenz	Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Propranolol.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the antihypertensive activities of Propranolol.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Propranolol which could result in a higher serum level.
Pimozide	Pimozide The metabolism of Pimozide can be decreased when combined with Propranolol.
Enalapril	Enalapril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Enalapril.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Propranolol.
Amiodarone	Amiodarone The therapeutic efficacy of Propranolol can be increased when used in combination with Amiodarone.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Propranolol which could result in a higher serum level.
Buspirone	Buspirone Buspirone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ciprofloxacin	Ciprofloxacin The metabolism of Propranolol can be decreased when combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the antihypertensive activities of Propranolol.
Diclofenac	Diclofenac Diclofenac may decrease the antihypertensive activities of Propranolol.
Fluoxetine	Fluoxetine The serum concentration of Propranolol can be increased when it is combined with Fluoxetine.
Nimodipine	Nimodipine The risk or severity of bradycardia can be increased when Nimodipine is combined with Propranolol.
Interferon Alfa-2b Injection	Interferon Alfa-2b Injection The metabolism of Propranolol can be decreased when combined with Interferon alfa-2b.
Clozapine	Clozapine The serum concentration of Propranolol can be increased when it is combined with Clozapine.
Estazolam	Estazolam Propranolol may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin	Idarubicin The metabolism of Idarubicin can be decreased when combined with Propranolol.
Ofloxacin	Ofloxacin The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ofloxacin.
Didanosine	Didanosine Propranolol may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection	Pentostatin Injection Pentostatin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Clarithromycin	Clarithromycin The metabolism of Propranolol can be decreased when combined with Clarithromycin.
Benazepril	Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Propranolol.
Etodolac	Etodolac Etodolac may decrease the antihypertensive activities of Propranolol.
Felodipine	Felodipine The risk or severity of bradycardia can be increased when Propranolol is combined with Felodipine.
Fosinopril	Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Propranolol.
Nabumetone	Nabumetone Nabumetone may decrease the antihypertensive activities of Propranolol.
Pravastatin	Pravastatin The metabolism of Pravastatin can be increased when combined with Propranolol.
Quinapril	Quinapril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Quinapril.
Ramipril	Ramipril Ramipril may increase the hypotensive activities of Propranolol.
Simvastatin	Simvastatin The metabolism of Simvastatin can be decreased when combined with Propranolol.
Amlodipine	Amlodipine The risk or severity of bradycardia can be increased when Amlodipine is combined with Propranolol.
Teniposide Injection	Teniposide Injection The metabolism of Propranolol can be decreased when combined with Teniposide.
Itraconazole	Itraconazole The metabolism of Propranolol can be decreased when combined with Itraconazole.
Lisinopril	Lisinopril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Lisinopril.
Oxaprozin	Oxaprozin Oxaprozin may decrease the antihypertensive activities of Propranolol.
Rifabutin	Rifabutin The serum concentration of Propranolol can be decreased when it is combined with Rifabutin.
Sotalol	Sotalol Propranolol may increase the arrhythmogenic activities of Sotalol.
Bisoprolol	Bisoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Propranolol.
Zolpidem	Zolpidem The metabolism of Propranolol can be decreased when combined with Zolpidem.
Doxazosin	Doxazosin Propranolol may increase the orthostatic hypotensive activities of Doxazosin.
Terazosin	Terazosin Propranolol may increase the orthostatic hypotensive activities of Terazosin.
Isradipine	Isradipine The risk or severity of bradycardia can be increased when Isradipine is combined with Propranolol.
Omeprazole	Omeprazole The serum concentration of Propranolol can be increased when it is combined with Omeprazole.
Cisapride	Cisapride The risk or severity of QTc prolongation can be increased when Propranolol is combined with Cisapride.
Venlafaxine	Venlafaxine The metabolism of Propranolol can be decreased when combined with Venlafaxine.
Nizatidine	Nizatidine Nizatidine may increase the bradycardic activities of Propranolol.
Fluvoxamine	Fluvoxamine The serum concentration of Propranolol can be increased when it is combined with Fluvoxamine.
Nefazodone	Nefazodone The serum concentration of Nefazodone can be increased when it is combined with Propranolol.
Lamotrigine	Lamotrigine The risk or severity of bradycardia can be increased when Lamotrigine is combined with Propranolol.
Losartan	Losartan The serum concentration of Propranolol can be increased when it is combined with Losartan.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Tramadol	Tramadol The metabolism of Tramadol can be decreased when combined with Propranolol.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Propranolol can be decreased when combined with Vinorelbine.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Moexipril	Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Propranolol.
Lansoprazole	Lansoprazole The serum concentration of Propranolol can be increased when it is combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Propranolol.
Nicardipine	Nicardipine The serum concentration of Propranolol can be increased when it is combined with Nicardipine.
Bupropion	Bupropion The metabolism of Propranolol can be decreased when combined with Bupropion.
Ticlopidine	Ticlopidine The serum concentration of Propranolol can be increased when it is combined with Ticlopidine.
Saquinavir	Saquinavir The metabolism of Saquinavir can be decreased when combined with Propranolol.
Metformin	Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Propranolol.
Dalteparin Injection	Dalteparin Injection The risk or severity of hyperkalemia can be increased when Propranolol is combined with Dalteparin.
Nisoldipine	Nisoldipine The risk or severity of bradycardia can be increased when Propranolol is combined with Nisoldipine.
Lamivudine	Lamivudine The serum concentration of Lamivudine can be increased when it is combined with Propranolol.
Riluzole	Riluzole The metabolism of Riluzole can be decreased when combined with Propranolol.
Amifostine Injection	Amifostine Injection Propranolol may increase the hypotensive activities of Amifostine.
Acarbose	Acarbose The therapeutic efficacy of Propranolol can be increased when used in combination with Acarbose.
Glimepiride	Glimepiride Propranolol may increase the arrhythmogenic activities of Glimepiride.
Gemcitabine Injection	Gemcitabine Injection Gemcitabine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Indinavir	Indinavir The metabolism of Propranolol can be decreased when combined with Indinavir.
Ritonavir	Ritonavir The serum concentration of Propranolol can be increased when it is combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Propranolol.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Propranolol may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine	Clomipramine The serum concentration of Propranolol can be increased when it is combined with Clomipramine.
Zafirlukast	Zafirlukast The serum concentration of Propranolol can be increased when it is combined with Zafirlukast.
Fosfomycin	Fosfomycin Propranolol may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine	Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Propranolol.
Trandolapril	Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Propranolol.
Topiramate	Topiramate The serum concentration of Propranolol can be increased when it is combined with Topiramate.
Zileuton	Zileuton The metabolism of Zileuton can be decreased when combined with Propranolol.
Valsartan	Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Propranolol.
Insulin Lispro Injection	Insulin Lispro Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin lispro.
Pramipexole	Pramipexole The serum concentration of Propranolol can be increased when it is combined with Pramipexole.
Donepezil	Donepezil Propranolol may increase the bradycardic activities of Donepezil.
Nelfinavir	Nelfinavir The metabolism of Propranolol can be decreased when combined with Nelfinavir.
Azithromycin	Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Propranolol.
Carvedilol	Carvedilol The risk or severity of bradycardia can be increased when Carvedilol is combined with Propranolol.
Nilutamide	Nilutamide The serum concentration of Propranolol can be increased when it is combined with Nilutamide.
Flutamide	Flutamide The metabolism of Propranolol can be decreased when combined with Flutamide.
Selegiline	Selegiline Selegiline may increase the hypotensive activities of Propranolol.
Bicalutamide	Bicalutamide The serum concentration of Propranolol can be increased when it is combined with Bicalutamide.
Sertraline	Sertraline The serum concentration of Propranolol can be increased when it is combined with Sertraline.
Propafenone	Propafenone The serum concentration of Propafenone can be increased when it is combined with Propranolol.
Letrozole	Letrozole The serum concentration of Propranolol can be increased when it is combined with Letrozole.
Irbesartan	Irbesartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Irbesartan.
Tamsulosin	Tamsulosin Propranolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole	Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Propranolol.
Finasteride	Finasteride The metabolism of Finasteride can be decreased when combined with Propranolol.
Quetiapine	Quetiapine Propranolol may increase the hypotensive activities of Quetiapine.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cetirizine	Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Propranolol.
Tolcapone	Tolcapone Tolcapone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Citalopram	Citalopram The serum concentration of Propranolol can be increased when it is combined with Citalopram.
Capecitabine	Capecitabine Propranolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz	Efavirenz The serum concentration of Propranolol can be decreased when it is combined with Efavirenz.
Abacavir	Abacavir Propranolol may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil	Sildenafil The serum concentration of Propranolol can be increased when it is combined with Sildenafil.
Pioglitazone	Pioglitazone The therapeutic efficacy of Propranolol can be increased when used in combination with Pioglitazone.
Celecoxib	Celecoxib Celecoxib may decrease the antihypertensive activities of Propranolol.
Rosiglitazone	Rosiglitazone The therapeutic efficacy of Propranolol can be increased when used in combination with Rosiglitazone.
Tolterodine	Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Propranolol.
Thalidomide	Thalidomide The serum concentration of Propranolol can be increased when it is combined with Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Aluminum Hydroxide	Aluminum Hydroxide The serum concentration of Propranolol can be decreased when it is combined with Aluminum hydroxide.
Colesevelam	Colesevelam Colesevelam can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide	Balsalazide Balsalazide may decrease the antihypertensive activities of Propranolol.
Nateglinide	Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Propranolol.
Galantamine	Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Propranolol.
Rabeprazole	Rabeprazole The serum concentration of Propranolol can be increased when it is combined with Rabeprazole.
Terbinafine	Terbinafine The metabolism of Propranolol can be decreased when combined with Terbinafine.

* This branded product is no longer on the market. Generic alternatives may be available.

Propranolol (Cardiovascular)

On this page